粘膜下注入剤の世界市場調査レポート2023年版Global Submucosal Injection Agent Market Research Report 2023 粘膜下注入剤の世界市場は、2022年に9743万米ドル、2029年には1億6351万米ドルに達すると予測され、予測期間2023-2029年に7.67%のCAGRを記録しています。市場規模を推定する際には、COVID-19とオランダ・ウクライ... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー粘膜下注入剤の世界市場は、2022年に9743万米ドル、2029年には1億6351万米ドルに達すると予測され、予測期間2023-2029年に7.67%のCAGRを記録しています。市場規模を推定する際には、COVID-19とオランダ・ウクライナ戦争の影響を考慮しました。レポートスコープ 本レポートは、粘膜下注入剤の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、粘膜下注入剤に関するビジネス上の意思決定に役立てることを目的としています。 粘膜下注射剤の市場規模、推計、予測は、2022年を基準年とみなし、2018年から2022年までの期間の履歴と予測データを、販売量(K Unit)と収益($ million)で提供しています。本レポートでは、世界の粘膜下注入剤市場を包括的に区分しています。タイプ別、用途別、プレイヤー別の製品に関する地域別市場規模も掲載しています。 市場をより深く理解するために、競争環境、主要な競合他社、それぞれの市場ランクのプロフィールを掲載しています。また、技術動向や新製品開発についても考察しています。 本レポートは、企業別、タイプ別、用途別、地域別に、市場全体とサブセグメントにまたがる収益、販売量、平均価格に関する情報を提供し、本市場の粘膜下注入剤メーカー、新規参入企業、産業チェーン関連企業のお役に立つでしょう。 会社別 精華楽 オベスコ内視鏡 GIサプライ コスモファーマシューティカルズ ボストンサイエンティフィック ザ・スタンダード マイクロテック内視鏡 エンドクロットプラス タイプ別セグメント シリンジタイプ アンプルタイプ アプリケーション別セグメント ホスピタルズ 外来手術センター スペシャリティクリニック 地域別消費量 北アメリカ U.S. カナダ メキシコ アジア太平洋 中国 日本 韓国 インド 東南アジア オーストラリア その他のアジア太平洋地域 ヨーロッパ ドイツ 連邦王国 フランス ロシア イタリア スペイン その他のヨーロッパ ラテンアメリカ ブラジル アルゼンチン コロンビア ラテンアメリカの残りの地域 目次1 Submucosal Injection Agent Market Overview 11.1 Product Definition 1 1.2 Submucosal Injection Agent by Type 1 1.2.1 Global Submucosal Injection Agent Market Value Comparison by Type (2023-2029) 2 1.2.2 Syringe Type 3 1.2.3 Ampoule Type 3 1.3 Submucosal Injection Agent by Application 4 1.4 Global Submucosal Injection Agent Market Size Estimates and Forecasts 6 1.4.1 Global Submucosal Injection Agent Revenue 2018-2029 6 1.4.2 Global Submucosal Injection Agent Sales 2018-2029 8 1.5 Assumptions and Limitations 8 2 Submucosal Injection Agent Market Competition by Manufacturers 10 2.1 Global Submucosal Injection Agent Sales Market Share by Manufacturers (2020-2023) 10 2.2 Global Submucosal Injection Agent Revenue Market Share by Manufacturers (2020-2023) 12 2.3 Global Submucosal Injection Agent Average Price by Manufacturers (2020-2023) 14 2.4 Global Key Players of Submucosal Injection Agent, Industry Ranking, 2021 VS 2022 VS 2023 14 2.5 Global Key Manufacturers of Submucosal Injection Agent, Manufacturing Sites & Headquarters 15 2.6 Global Key Manufacturers of Submucosal Injection Agent, Product Type 15 2.7 Global Submucosal Injection Agent Market Competitive Situation and Trends 16 2.7.1 Global Submucosal Injection Agent Market Concentration Rate 16 2.7.2 The Global 3 and 5 Largest Submucosal Injection Agent Players Market Share by Revenue 17 2.7.3 Global Submucosal Injection Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 18 3 Global Submucosal Injection Agent Market Scenario by Region 19 3.1 Global Submucosal Injection Agent Market Size by Region: 2018 Versus 2022 Versus 2029 19 3.2 Global Submucosal Injection Agent Sales by Region: 2018-2029 20 3.2.1 Global Submucosal Injection Agent Sales by Region: 2018-2023 20 3.2.2 Global Submucosal Injection Agent Sales by Region: 2024-2029 20 3.3 Global Submucosal Injection Agent Revenue by Region: 2018-2029 21 3.3.1 Global Submucosal Injection Agent Revenue by Region: 2018-2023 21 3.3.2 Global Submucosal Injection Agent Revenue by Region: 2024-2029 22 3.4 North America Submucosal Injection Agent Market Facts & Figures by Country 22 3.4.1 North America Submucosal Injection Agent Sales by Country (2018-2029) 22 3.4.2 North America Submucosal Injection Agent Revenue by Country (2018-2029) 23 3.4.3 United States 25 3.4.4 Canada 25 3.4.5 Mexico 26 3.5 Europe Submucosal Injection Agent Market Facts & Figures by Country 26 3.5.1 Europe Submucosal Injection Agent Sales by Country (2018-2029) 26 3.5.2 Europe Submucosal Injection Agent Revenue by Country (2018-2029) 27 3.5.3 Germany 29 3.5.4 France 29 3.5.5 U.K. 30 3.5.6 Italy 30 3.5.7 Russia 31 3.5.8 Spain 31 3.6 Asia Pacific Submucosal Injection Agent Market Facts & Figures by Region 32 3.6.1 Asia Pacific Submucosal Injection Agent Sales by Region (2018-2029) 32 3.6.2 Asia Pacific Submucosal Injection Agent Revenue by Region (2018-2029) 33 3.6.3 China 35 3.6.4 Japan 35 3.6.5 South Korea 36 3.6.6 India 36 3.6.7 Australia 37 3.6.8 Southeast Asia 37 3.7 Latin America Submucosal Injection Agent Market Facts & Figures by Country 38 3.7.1 Latin America Submucosal Injection Agent Sales by Country (2018-2029) 38 3.7.2 Latin America Submucosal Injection Agent Revenue by Country 39 3.7.3 Brazil 40 3.7.4 Argentina 41 3.7.5 Colombia 41 3.8 Middle East and Africa Submucosal Injection Agent Market Facts & Figures by Country 42 3.8.1 Middle East and Africa Submucosal Injection Agent Sales by Country (2018-2029) 42 3.8.2 Middle East and Africa Submucosal Injection Agent Revenue by Country 43 3.8.3 Middle East 44 3.8.4 Africa 45 4 Segment by Type 46 4.1 Global Submucosal Injection Agent Sales by Type (2018-2029) 46 4.1.1 Global Submucosal Injection Agent Sales by Type (2018-2023) 46 4.1.2 Global Submucosal Injection Agent Sales by Type (2024-2029) 46 4.1.3 Global Submucosal Injection Agent Sales Market Share by Type (2018-2029) 46 4.2 Global Submucosal Injection Agent Revenue by Type (2018-2029) 47 4.2.1 Global Submucosal Injection Agent Revenue by Type (2018-2023) 47 4.2.2 Global Submucosal Injection Agent Revenue by Type (2024-2029) 47 4.2.3 Global Submucosal Injection Agent Revenue Market Share by Type (2018-2029) 48 4.3 Global Submucosal Injection Agent Price by Type (2018-2029) 49 5 Segment by Application 50 5.1 Global Submucosal Injection Agent Sales by Application (2018-2029) 50 5.1.1 Global Submucosal Injection Agent Sales by Application (2018-2023) 50 5.1.2 Global Submucosal Injection Agent Sales by Application (2024-2029) 50 5.1.3 Global Submucosal Injection Agent Sales Market Share by Application (2018-2029) 50 5.2 Global Submucosal Injection Agent Revenue by Application (2018-2029) 51 5.2.1 Global Submucosal Injection Agent Revenue by Application (2018-2023) 51 5.2.2 Global Submucosal Injection Agent Revenue by Application (2024-2029) 52 5.2.3 Global Submucosal Injection Agent Revenue Market Share by Application (2018-2029) 52 5.3 Global Submucosal Injection Agent Price by Application (2018-2029) 53 6 Key Companies Profiled 54 6.1 Seikagaku 54 6.1.1 Seikagaku Corporation Information 54 6.1.2 Seikagaku Introduction and Business Overview 54 6.1.3 Seikagaku Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 54 6.1.4 Seikagaku Submucosal Injection Agent Products Offered 55 6.2 Ovesco Endoscopy 55 6.2.1 Ovesco Endoscopy Corporation Information 55 6.2.2 Ovesco Endoscopy Introduction and Business Overview 56 6.2.3 Ovesco Endoscopy Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 56 6.2.4 Ovesco Endoscopy Submucosal Injection Agent Products Offered 56 6.3 GI Supply 57 6.3.1 GI Supply Corporation Information 57 6.3.2 GI Supply Introduction and Business Overview 58 6.3.3 GI Supply Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 58 6.3.4 GI Supply Submucosal Injection Agent Products Offered 58 6.4 Cosmo Pharmaceuticals 59 6.4.1 Cosmo Pharmaceuticals Corporation Information 59 6.4.2 Cosmo Pharmaceuticals Introduction and Business Overview 59 6.4.3 Cosmo Pharmaceuticals Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 60 6.4.4 Cosmo Pharmaceuticals Submucosal Injection Agent Products Offered 60 6.5 Boston Scientific 61 6.5.1 Boston Scientific Corporation Information 61 6.5.2 Boston Scientific Introduction and Business Overview 61 6.5.3 Boston Scientific Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 61 6.5.4 Boston Scientific Submucosal Injection Agent Products Offered 62 6.6 The Standard 62 6.6.1 The Standard Corporation Information 62 6.6.2 The Standard Introduction and Business Overview 63 6.6.3 The Standard Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 63 6.6.4 The Standard Submucosal Injection Agent Products Offered 63 6.7 Micro-Tech Endoscopy 64 6.7.1 Micro-Tech Endoscopy Corporation Information 64 6.7.2 Micro-Tech Endoscopy Introduction and Business Overview 64 6.7.3 Micro-Tech Endoscopy Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 65 6.7.4 Micro-Tech Endoscopy Submucosal Injection Agent Products Offered 65 6.8 EndoClot Plus 66 6.8.1 EndoClot Plus Corporation Information 66 6.8.2 EndoClot Plus Introduction and Business Overview 66 6.8.3 EndoClot Plus Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 67 6.8.4 EndoClot Plus Submucosal Injection Agent Products Offered 67 7 Industry Chain and Sales Channels Analysis 68 7.1 Submucosal Injection Agent Industry Chain Analysis 68 7.2 Submucosal Injection Agent Key Raw Materials 68 7.2.1 Key Raw Materials 68 7.2.2 Raw Materials Key Suppliers 70 7.2.3 Raw Materials 70 7.2.4 Labor Cost 71 7.2.5 Manufacturing Expenses 71 7.3 Submucosal Injection Agent Sales and Marketing 71 7.3.1 Submucosal Injection Agent Distributors 71 7.4 Submucosal Injection Agent Customers 72 8 Submucosal Injection Agent Market Dynamics 74 8.1 Submucosal Injection Agent Industry Trends 74 8.2 Submucosal Injection Agent Market Drivers 74 8.3 Submucosal Injection Agent Market Challenges 75 9 Research Findings and Conclusion 76 10 Methodology and Data Source 77 10.1 Methodology/Research Approach 77 10.1.1 Research Programs/Design 77 10.1.2 Market Size Estimation 77 10.1.3 Market Breakdown and Data Triangulation 79 10.2 Data Source 80 10.2.1 Secondary Sources 80 10.2.2 Primary Sources 81 10.3 Author List 83 10.4 Disclaimer 85
SummaryThe global Submucosal Injection Agent market was valued at US$ 97.43 million in 2022 and is anticipated to reach US$ 163.51 million by 2029, witnessing a CAGR of 7.67% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Table of Contents1 Submucosal Injection Agent Market Overview 11.1 Product Definition 1 1.2 Submucosal Injection Agent by Type 1 1.2.1 Global Submucosal Injection Agent Market Value Comparison by Type (2023-2029) 2 1.2.2 Syringe Type 3 1.2.3 Ampoule Type 3 1.3 Submucosal Injection Agent by Application 4 1.4 Global Submucosal Injection Agent Market Size Estimates and Forecasts 6 1.4.1 Global Submucosal Injection Agent Revenue 2018-2029 6 1.4.2 Global Submucosal Injection Agent Sales 2018-2029 8 1.5 Assumptions and Limitations 8 2 Submucosal Injection Agent Market Competition by Manufacturers 10 2.1 Global Submucosal Injection Agent Sales Market Share by Manufacturers (2020-2023) 10 2.2 Global Submucosal Injection Agent Revenue Market Share by Manufacturers (2020-2023) 12 2.3 Global Submucosal Injection Agent Average Price by Manufacturers (2020-2023) 14 2.4 Global Key Players of Submucosal Injection Agent, Industry Ranking, 2021 VS 2022 VS 2023 14 2.5 Global Key Manufacturers of Submucosal Injection Agent, Manufacturing Sites & Headquarters 15 2.6 Global Key Manufacturers of Submucosal Injection Agent, Product Type 15 2.7 Global Submucosal Injection Agent Market Competitive Situation and Trends 16 2.7.1 Global Submucosal Injection Agent Market Concentration Rate 16 2.7.2 The Global 3 and 5 Largest Submucosal Injection Agent Players Market Share by Revenue 17 2.7.3 Global Submucosal Injection Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 18 3 Global Submucosal Injection Agent Market Scenario by Region 19 3.1 Global Submucosal Injection Agent Market Size by Region: 2018 Versus 2022 Versus 2029 19 3.2 Global Submucosal Injection Agent Sales by Region: 2018-2029 20 3.2.1 Global Submucosal Injection Agent Sales by Region: 2018-2023 20 3.2.2 Global Submucosal Injection Agent Sales by Region: 2024-2029 20 3.3 Global Submucosal Injection Agent Revenue by Region: 2018-2029 21 3.3.1 Global Submucosal Injection Agent Revenue by Region: 2018-2023 21 3.3.2 Global Submucosal Injection Agent Revenue by Region: 2024-2029 22 3.4 North America Submucosal Injection Agent Market Facts & Figures by Country 22 3.4.1 North America Submucosal Injection Agent Sales by Country (2018-2029) 22 3.4.2 North America Submucosal Injection Agent Revenue by Country (2018-2029) 23 3.4.3 United States 25 3.4.4 Canada 25 3.4.5 Mexico 26 3.5 Europe Submucosal Injection Agent Market Facts & Figures by Country 26 3.5.1 Europe Submucosal Injection Agent Sales by Country (2018-2029) 26 3.5.2 Europe Submucosal Injection Agent Revenue by Country (2018-2029) 27 3.5.3 Germany 29 3.5.4 France 29 3.5.5 U.K. 30 3.5.6 Italy 30 3.5.7 Russia 31 3.5.8 Spain 31 3.6 Asia Pacific Submucosal Injection Agent Market Facts & Figures by Region 32 3.6.1 Asia Pacific Submucosal Injection Agent Sales by Region (2018-2029) 32 3.6.2 Asia Pacific Submucosal Injection Agent Revenue by Region (2018-2029) 33 3.6.3 China 35 3.6.4 Japan 35 3.6.5 South Korea 36 3.6.6 India 36 3.6.7 Australia 37 3.6.8 Southeast Asia 37 3.7 Latin America Submucosal Injection Agent Market Facts & Figures by Country 38 3.7.1 Latin America Submucosal Injection Agent Sales by Country (2018-2029) 38 3.7.2 Latin America Submucosal Injection Agent Revenue by Country 39 3.7.3 Brazil 40 3.7.4 Argentina 41 3.7.5 Colombia 41 3.8 Middle East and Africa Submucosal Injection Agent Market Facts & Figures by Country 42 3.8.1 Middle East and Africa Submucosal Injection Agent Sales by Country (2018-2029) 42 3.8.2 Middle East and Africa Submucosal Injection Agent Revenue by Country 43 3.8.3 Middle East 44 3.8.4 Africa 45 4 Segment by Type 46 4.1 Global Submucosal Injection Agent Sales by Type (2018-2029) 46 4.1.1 Global Submucosal Injection Agent Sales by Type (2018-2023) 46 4.1.2 Global Submucosal Injection Agent Sales by Type (2024-2029) 46 4.1.3 Global Submucosal Injection Agent Sales Market Share by Type (2018-2029) 46 4.2 Global Submucosal Injection Agent Revenue by Type (2018-2029) 47 4.2.1 Global Submucosal Injection Agent Revenue by Type (2018-2023) 47 4.2.2 Global Submucosal Injection Agent Revenue by Type (2024-2029) 47 4.2.3 Global Submucosal Injection Agent Revenue Market Share by Type (2018-2029) 48 4.3 Global Submucosal Injection Agent Price by Type (2018-2029) 49 5 Segment by Application 50 5.1 Global Submucosal Injection Agent Sales by Application (2018-2029) 50 5.1.1 Global Submucosal Injection Agent Sales by Application (2018-2023) 50 5.1.2 Global Submucosal Injection Agent Sales by Application (2024-2029) 50 5.1.3 Global Submucosal Injection Agent Sales Market Share by Application (2018-2029) 50 5.2 Global Submucosal Injection Agent Revenue by Application (2018-2029) 51 5.2.1 Global Submucosal Injection Agent Revenue by Application (2018-2023) 51 5.2.2 Global Submucosal Injection Agent Revenue by Application (2024-2029) 52 5.2.3 Global Submucosal Injection Agent Revenue Market Share by Application (2018-2029) 52 5.3 Global Submucosal Injection Agent Price by Application (2018-2029) 53 6 Key Companies Profiled 54 6.1 Seikagaku 54 6.1.1 Seikagaku Corporation Information 54 6.1.2 Seikagaku Introduction and Business Overview 54 6.1.3 Seikagaku Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 54 6.1.4 Seikagaku Submucosal Injection Agent Products Offered 55 6.2 Ovesco Endoscopy 55 6.2.1 Ovesco Endoscopy Corporation Information 55 6.2.2 Ovesco Endoscopy Introduction and Business Overview 56 6.2.3 Ovesco Endoscopy Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 56 6.2.4 Ovesco Endoscopy Submucosal Injection Agent Products Offered 56 6.3 GI Supply 57 6.3.1 GI Supply Corporation Information 57 6.3.2 GI Supply Introduction and Business Overview 58 6.3.3 GI Supply Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 58 6.3.4 GI Supply Submucosal Injection Agent Products Offered 58 6.4 Cosmo Pharmaceuticals 59 6.4.1 Cosmo Pharmaceuticals Corporation Information 59 6.4.2 Cosmo Pharmaceuticals Introduction and Business Overview 59 6.4.3 Cosmo Pharmaceuticals Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 60 6.4.4 Cosmo Pharmaceuticals Submucosal Injection Agent Products Offered 60 6.5 Boston Scientific 61 6.5.1 Boston Scientific Corporation Information 61 6.5.2 Boston Scientific Introduction and Business Overview 61 6.5.3 Boston Scientific Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 61 6.5.4 Boston Scientific Submucosal Injection Agent Products Offered 62 6.6 The Standard 62 6.6.1 The Standard Corporation Information 62 6.6.2 The Standard Introduction and Business Overview 63 6.6.3 The Standard Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 63 6.6.4 The Standard Submucosal Injection Agent Products Offered 63 6.7 Micro-Tech Endoscopy 64 6.7.1 Micro-Tech Endoscopy Corporation Information 64 6.7.2 Micro-Tech Endoscopy Introduction and Business Overview 64 6.7.3 Micro-Tech Endoscopy Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 65 6.7.4 Micro-Tech Endoscopy Submucosal Injection Agent Products Offered 65 6.8 EndoClot Plus 66 6.8.1 EndoClot Plus Corporation Information 66 6.8.2 EndoClot Plus Introduction and Business Overview 66 6.8.3 EndoClot Plus Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2023) 67 6.8.4 EndoClot Plus Submucosal Injection Agent Products Offered 67 7 Industry Chain and Sales Channels Analysis 68 7.1 Submucosal Injection Agent Industry Chain Analysis 68 7.2 Submucosal Injection Agent Key Raw Materials 68 7.2.1 Key Raw Materials 68 7.2.2 Raw Materials Key Suppliers 70 7.2.3 Raw Materials 70 7.2.4 Labor Cost 71 7.2.5 Manufacturing Expenses 71 7.3 Submucosal Injection Agent Sales and Marketing 71 7.3.1 Submucosal Injection Agent Distributors 71 7.4 Submucosal Injection Agent Customers 72 8 Submucosal Injection Agent Market Dynamics 74 8.1 Submucosal Injection Agent Industry Trends 74 8.2 Submucosal Injection Agent Market Drivers 74 8.3 Submucosal Injection Agent Market Challenges 75 9 Research Findings and Conclusion 76 10 Methodology and Data Source 77 10.1 Methodology/Research Approach 77 10.1.1 Research Programs/Design 77 10.1.2 Market Size Estimation 77 10.1.3 Market Breakdown and Data Triangulation 79 10.2 Data Source 80 10.2.1 Secondary Sources 80 10.2.2 Primary Sources 81 10.3 Author List 83 10.4 Disclaimer 85
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポート
QYResearch 社の最新刊レポート本レポートと同じKEY WORD(injection)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/12 10:27 143.85 円 158.71 円 190.22 円 |